The regulatory and market access environment for biosimilars is constantly evolving. For a company seeking to develop a biosimilar for multiple markets, staying ahead of the similarities and differences between each country can be a major challenge. The Access & Reimbursement Overview allows rapid assessment of key parameters including the scope of biosimilars guidelines, choice of reference product, pricing mechanisms for biosimilars, and strategies in place to drive uptake across the United States, EU5, Japan, Australia, Canada, and the leading growth markets.